BRPI0514954A - method for killing or inactivating microorganisms in mammalian tissue, antimicrobial composition, and methods for decolonizing at least a portion of an individual's nasal cavities, anterior nostrils, and / or nasopharynx to decolonizing at least a portion of the esophageal cavity of an individual, to treat a middle ear infection in an individual, to treat chronic sinusitis in an individual, to treat and / or prevent an infection in an individual's skin, mucosal tissue and / or wound, to make a composition antimicrobial - Google Patents
method for killing or inactivating microorganisms in mammalian tissue, antimicrobial composition, and methods for decolonizing at least a portion of an individual's nasal cavities, anterior nostrils, and / or nasopharynx to decolonizing at least a portion of the esophageal cavity of an individual, to treat a middle ear infection in an individual, to treat chronic sinusitis in an individual, to treat and / or prevent an infection in an individual's skin, mucosal tissue and / or wound, to make a composition antimicrobialInfo
- Publication number
- BRPI0514954A BRPI0514954A BRPI0514954-1A BRPI0514954A BRPI0514954A BR PI0514954 A BRPI0514954 A BR PI0514954A BR PI0514954 A BRPI0514954 A BR PI0514954A BR PI0514954 A BRPI0514954 A BR PI0514954A
- Authority
- BR
- Brazil
- Prior art keywords
- individual
- treat
- decolonizing
- antimicrobial
- infection
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 230000000845 anti-microbial effect Effects 0.000 title abstract 5
- 244000005700 microbiome Species 0.000 title abstract 3
- 210000001519 tissue Anatomy 0.000 title abstract 3
- 206010009137 Chronic sinusitis Diseases 0.000 title abstract 2
- 206010033078 Otitis media Diseases 0.000 title abstract 2
- 208000027157 chronic rhinosinusitis Diseases 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 208000022760 infectious otitis media Diseases 0.000 title abstract 2
- 210000004400 mucous membrane Anatomy 0.000 title abstract 2
- 230000000415 inactivating effect Effects 0.000 title 1
- 210000003928 nasal cavity Anatomy 0.000 title 1
- 210000001989 nasopharynx Anatomy 0.000 title 1
- VPWNQTHUCYMVMZ-UHFFFAOYSA-N 4,4'-sulfonyldiphenol Chemical class C1=CC(O)=CC=C1S(=O)(=O)C1=CC=C(O)C=C1 VPWNQTHUCYMVMZ-UHFFFAOYSA-N 0.000 abstract 1
- 229930185605 Bisphenol Chemical class 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 229940051881 anilide analgesics and antipyretics Drugs 0.000 abstract 1
- 150000003931 anilides Chemical class 0.000 abstract 1
- 230000003515 anti-microbian Effects 0.000 abstract 1
- 230000002421 anti-septic effect Effects 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical class C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 210000004379 membrane Anatomy 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 150000002989 phenols Chemical class 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
MéTODO PARA MATAR OU INATIVAR MICROORGANISMOS NO TECIDO DE MAMìFERO, COMPOSIçãO ANTIMICROBIANA, E, MéTODOS PARA DESCOLONIZAR PELO MENOS UMA PORçãO DAS CAVIDADES NASAIS, DAS NARINAS ANTERIORES, E/OU DA NASOFARINGE DE UM INDIVìDUO, PARA DESCOLONIZAR PELO MENOS UMA PORçãO DA CAVIDADE DO ESÈFAGO DE UM INDIVìDUO, PARA TRATAR UMA INFECçãO DE OUVIDO MéDIO EM UM INDIVìDUO, PARA TRATAR SINUSITE CRÈNICA EM UM INDIVìDUO, PARA TRATAR E/OU PREVENIR UMA INFECçãO NA PELE, NO TECIDO MUCOSAL E/OU NA FERIDA DE UM INDIVìDUO, PARA FAZER UMA COMPOSIçãO ANTIMICROBIANA Composições antimicrobianas, especialmente aquelas úteis quando aplicadas topicamente, tais aos tecidos mucosais (isto e, membranas mucosais), que incluem um anti-séptico selecionado do grupo que consiste de fenóis halogenados, bisfenóis, difenil éteres, anilidas e derivados dos mesmos, e combinações dos mesmos. As composições podem também incluir um componente melhorador, um tensoativo, um componente hidrofóbico, e/ou um componente hidrofilico. Tais composições fornecem atividade antimicrobiana tópica eficaz e são, com isso, úteis no tratamento e/ou prevenção de condições que são causadas, ou agravadas por, microorganismos (incluindo vírus).METHOD FOR KILLING OR INACTIVATE MICROORGANISMS IN MAMMALIAN TISSUE, ANTIMICROBIAN COMPOSITION, AND METHODS FOR DECOLONIZING AT LEAST A PART OF NASAL CAUSES, FORMER NARINAS, AND / OR NASOFARESO CABINAGE OF THE PERSONAL FEMALE Of an individual, to treat a middle ear infection in an individual, to treat chronic sinusitis in an individual, to treat and / or to prevent an infection in the skin, mucous tissue and / or wound of a composite person Antimicrobial Antimicrobial compositions, especially those useful when applied topically, such as mucosal tissues (i.e., mucosal membranes), which include an antiseptic selected from the group consisting of halogenated phenols, bisphenols, diphenyl ethers, anilides and derivatives thereof, and combinations thereof. The compositions may also include an enhancer component, a surfactant, a hydrophobic component, and / or a hydrophilic component. Such compositions provide effective topical antimicrobial activity and are therefore useful in treating and / or preventing conditions that are caused or aggravated by microorganisms (including viruses).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93617106A | 2004-09-07 | 2004-09-07 | |
| PCT/US2005/032024 WO2006029278A2 (en) | 2004-09-07 | 2005-09-07 | Phenolic antiseptic compositions and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0514954A true BRPI0514954A (en) | 2008-07-01 |
Family
ID=39545129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0514954-1A BRPI0514954A (en) | 2004-09-07 | 2005-09-07 | method for killing or inactivating microorganisms in mammalian tissue, antimicrobial composition, and methods for decolonizing at least a portion of an individual's nasal cavities, anterior nostrils, and / or nasopharynx to decolonizing at least a portion of the esophageal cavity of an individual, to treat a middle ear infection in an individual, to treat chronic sinusitis in an individual, to treat and / or prevent an infection in an individual's skin, mucosal tissue and / or wound, to make a composition antimicrobial |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BRPI0514954A (en) |
-
2005
- 2005-09-07 BR BRPI0514954-1A patent/BRPI0514954A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0414220A (en) | antimicrobial composition, methods of preventing and / or treating an affliction, a patient for a common cold and / or respiratory distress caused by a microbial infection, an infection in a patient's mammalian tissue, decolonizing at least a portion of the nasal cavities, anterior nostrils and / or nasopharynx, at least a portion of the throat / esophagus and at least a portion of the oral cavity of a microorganism patient, killing or inactivating microorganism, providing residual antomicrobial efficacy on a surface and a bored mammal of a patient, treat a middle ear infection, chronic sinusitis and impetigo on the skin and a burn, manufacture an antimicrobial composition, and release an antimicrobial component to a surface, and release system for an antimicrobial component. | |
| BRPI0514920A (en) | method for killing or inactivating microorganisms in mammalian tissue, antimicrobial composition, and methods for killing or inactivating microorganisms in mammalian skin, for killing or inactivating microorganisms in mammalian tissue, and / or in an individual's wound, to decolonize at least a portion of an individual's esophageal cavity, to treat a middle ear infection in an individual, to treat chronic sinusitis in an individual, to treat impetigo on an individual's skin, and to make an antimicrobial composition | |
| TW200616605A (en) | Phenolic antiseptic compositions and methods of use | |
| BRPI1007379B8 (en) | pharmaceutical compositions for the treatment or prevention of oral infections by e. coli | |
| BRPI0520588B8 (en) | use of pharmaceutical compositions for the treatment of inner ear diseases | |
| JP2014240419A (en) | Anti-bacterial extracellular polysaccharide solvating system | |
| NZ718955A (en) | Compositions comprising povidone-iodine | |
| BR0210791A (en) | Composition having bacteristatic and bactericidal activity against bacterial spores and vegetative cells and process for treating food using it. | |
| BRPI0411856A (en) | compositions and methods for increasing telomerase activity | |
| WO2003041686A3 (en) | Improved therapy for topical diseases | |
| BR0111591A (en) | Compounds, pharmaceutical composition, and methods for elevating the growth hormone plasma level in a mammal, for the treatment of growth hormone secretion deficiency, for the treatment of growth retardation in children, for the treatment of metabolic disorders growth hormone secretion deficiency, particularly in elderly patients, and to promote wound healing, surgical recovery or recovery from debilitating diseases | |
| ATE245452T1 (en) | HYALURONATE LYASE AS A PENETRATION PROMOTER IN TOPICAL AGENTS | |
| BR9805318A (en) | Method for treating eye infections with azithromycin. | |
| BR0209327A (en) | Composition for treatment of drug-induced constipation | |
| ATE525084T1 (en) | USE OF AT LEAST ONE BOTULINUM NEUROTOXIN FOR THE TREATMENT OF PAIN RESULTING FROM THERAPEUTIC TREATMENTS FOR THE AIDS VIRUS | |
| BR112021025701A2 (en) | Isoxazoline parasiticide formulations and methods to treat blepharitis | |
| KR890003387A (en) | Double-stranded RMAs Composition with Local Activity | |
| MX2007012794A (en) | Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin. | |
| BR9914128A (en) | Antibiotic compositions for treatment of the eye, ear and nose | |
| BRPI0612931B8 (en) | composition for application to the skin | |
| DK2165704T3 (en) | Use of alverine in the treatment of skin diseases | |
| BRPI0512503A (en) | composition comprising lactic acid and lactoferrin | |
| WO2005094236A3 (en) | Activation of hypoxia-inducible gene expression | |
| RU2009144286A (en) | COMPOSITIONS WITH N-HALOGENICATED AMINO ACID AND ANTI-INFLAMMATORY COMPOUNDS | |
| EP2068892A1 (en) | Wound healing compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2166 DE 10/07/2012. |